Novel 2,4-diaminothiazol-5-one derivatives

Details for Australian Patent Application No. 2005261954 (hide)

Owner F.Hoffmann-La Roche AG

Inventors Chu, Xin-Jie; Zhao, Chunlin; Chen, Li; Lovey, Allen John

Agent Davies Collison Cave

Pub. Number AU-A-2005261954

PCT Pub. Number WO2006/005508

Priority 60/588,184 15.07.04 US

Filing date 7 July 2005

Wipo publication date 19 January 2006

International Classifications

C07D 277/20 (2006.01) Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings

A61K 31/426 (2006.01) - 1,3-Thiazoles

A61P 3/00 (2006.01) Drugs for disorders of the metabolism

Event Publications

8 February 2007 PCT application entered the National Phase

  PCT publication WO2006/005508 Priority application(s): WO2006/005508

2 February 2012 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2005261958-Granules for controlled release of Tamsulosin

2005261953-Pharmaceutical composition of piperazine derivatives